Inactive Instrument

Company Genomic Vision

Equities

GV

FR0011799907

Biotechnology & Medical Research

Business Summary

Genomic Vision specializes in developing genetic diseases diagnosis tests and cancer genomic analysis. The group uses molecular combing technology which allows direct visualization of DNA individual molecules in order to detect the quantitative and qualitative changes of the genome and determine their role in targeted pathology. The activity is organized around 3 sources of income:

- sales of equipment and consumables: to academic laboratory centers using the molecular combing technology for research purposes;

- license and royalties income: income from collaboration with Quest Diagnostics;

- sales of software, testing kits and related consumables.

Number of employees: 33

Managers

Managers TitleAgeSince
Chief Executive Officer - 04-06-10
Director of Finance/CFO - 22-07-31
Chief Tech/Sci/R&D Officer - 21-10-12
Corporate Officer/Principal - 22-07-10

Members of the board

Members of the board TitleAgeSince
Director/Board Member - 22-07-10
Chief Executive Officer - 04-06-10
Chairman - 22-07-10
Director/Board Member - 22-07-10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 385,886,117 377,646,318 ( 97.86 %) 780,120 ( 0.2022 %) 97.86 %

Company contact information

Génomic Vision SA

Green Square Batiment E 80-84, rue des Meuniers

92220, Bagneux

+

http://www.genomicvision.com
address Genomic Vision(GV)
  1. Stock Market
  2. Equities
  3. GV Stock
  4. Company Genomic Vision